Skip to main content
. 2010 Mar 26;2:83–96. doi: 10.2147/cmar.s7540

Figure 1.

Figure 1

Study schema for phase 2 randomized trial of bevacizumab or placebo in patients with previously treated metastatic renal cell carcinoma. Drawn from data of Yang JC et al.33

Abbreviations: ORR, overall response rate; TTP, time to progression; OS, overall survival.